Contact
DMABA-d10 NHS Ester

DMABA-d10 NHS Ester 640010 4-[di(methyl-d3)amino]-2,5-dioxo-1-pyrrolidinyl ester benzoic-2,3,5,6-d4 acid

DMABA-d10 NHS Ester
The DMABA NHS ester reagents were developed by Dr. Robert Murphy’s laboratory at the University of Colorado in order to create PE derivatives where all subclasses and potentially oxidized products could be universally detected using a common precursor ion in the positive ion mode by Mass Spectrometry.
d4-DMABA Derivatived Brain PE Extract.A. The positive ion electrospray mass spectrum of brain PE lipid extract.B. The NL141 scan of brain PE lipid extract.C. The positive ion electrospray mass spectrum of d4-DMABA derivatized brain PE lipid extract, which is shifted in mass +151 amu when compared with the spectrum of unlabeled brain PE extract.D. P195 amu to selectively detect the d4-DMABA labeled species in the brain PE extract.
Fragmentation of DMABA NHS Ester Reagents. (Described by Berry, et al.)
00000000
$0.00
Buy
Please confirm your location

Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate location button below.

For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!

*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada